Company
Ginkgo Bioworks
Ginkgo Bioworks pioneers autonomous laboratory systems that accelerate bioengineering for biopharma, agriculture, and industrial biotech. The company provides hardware, software, and cloud-based solutions enabling customers to design and optimize biological processes. Ginkgo also offers research services including AI-powered analysis, screening, and developability testing for antibodies and small molecules.
Ginkgo Bioworks is a publicly traded company operating in the biotech & pharma sector, based in USA. Leadership tracked by CEOInsider includes Jason Kelly (CEO).
Leadership
Current
Recent developments
AI summary of recent coverageRecent coverage has focused on Ginkgo Bioworks' advancement of autonomous laboratory technology, with the company operating over 100 robots conducting continuous experiments as part of a $47 million facility build. The headlines also reflect significant attention to broader industry debates around U.S.-China biotech competition, with Ginkgo's CEO weighing in on policy concerns regarding foreign investment and offshore drug discovery capabilities.
Summarized from the headlines in the sidebar; see each source for the full story.